Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis

Q Qingliang Ma S Shiyu Wang H Hong Xue L Linhui Ni P Putao Yuan Y Yang Shen (Beijing National Laboratory for Condensed Matter Physics, Institute of Physics) B Bingjie Zheng Q Qingqing Wang (Institute of Immunology, Zhejiang University School of Medicine) J Jiateng Zhang H Haoming Wang H Hongwei Xie C Chao Jiang (School of Chemistry and Chemical Engineering and State Key Laboratory of Synergistic Chem-Bio Synthesis) A An Qin S Shunwu Fan Z Ziang Xie Z Zhiwei Jie

Article Details

Volume / Issue Vol. 16, Issue 1
Published August 06, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (16)

Q

Qingliang Ma

S

Shiyu Wang

H

Hong Xue

L

Linhui Ni

P

Putao Yuan

Y

Yang Shen

Beijing National Laboratory for Condensed Matter Physics, Institute of Physics

B

Bingjie Zheng

Q

Qingqing Wang

Institute of Immunology, Zhejiang University School of Medicine

J

Jiateng Zhang

H

Haoming Wang

H

Hongwei Xie

C

Chao Jiang

School of Chemistry and Chemical Engineering and State Key Laboratory of Synergistic Chem-Bio Synthesis

A

An Qin

S

Shunwu Fan

Z

Ziang Xie

Z

Zhiwei Jie